90084-62-1

Upstream product

• 98-57-7 4-chlorophenyl methyl sulfone 

Downstream Products

• 17481-98-0 1-chloro-2,4-bis-methanesulfonyl-benzene 
• 7409-84-9 2-amino-5-(methylsulfonyl)benzenesulfonamide 
• 852675-21-9 R/S-N-(2-amino-5-methylsulfonylbenzenesulfonyl)-N'-2-butylthiourea 
• 852675-20-8 N-(2-amino-5-methylsulfonylbenzenesulfonyl)-N'-isopropylthiourea 
• 852675-19-5 N-(2-amino-5-methylsulfonylbenzenesulfonyl)-N'-ethylthiourea 
• 3544-47-6 2-chloro-5-(methylsulfonyl)benzenesulfonamide 

Relevant academic research and scientific papers

METHODS AND COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS AND VIRAL INFECTIONS

The invention generally relates to methods and compounds for treating proliferative disorders, viral infections, or both. In some embodiments, the invention provides an anticancer or antiviral compound including a substituted nitro phenoxy phenyl, a sulfonylurea, and an alkyl group. In some embodiments, the invention provides a method of treating a proliferative disorder or a viral infection including administering an anticancer or antiviral compound that binds to a thromboxane receptor, has preferential binding for either TPalpha (TPα) or TPbeta (ΤΡβ) receptor subtype.

Effect on KATP channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides

The present work explored 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides diversely substituted in the 7-position. Those compounds, structurally related to previously described potassium channel openers such as the benzothiadiazine dioxide BPDZ 73, we